India Adhesives Market
This presentation is the property of its rightful owner.
Sponsored Links
1 / 12

Global tissue engineered medical devices market forecast and opportunities,... PowerPoint PPT Presentation


Pharmaion offers latest market research report for "Global tissue engineered medical devices" that show the global tissue engineered medical devices market is anticipated to surpass US$ 26 billion by 2020.

Download Presentation

Global tissue engineered medical devices market forecast and...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Global tissue engineered medical devices market forecast and opportunities 2020

India Adhesives Market

Forecast & Opportunities, 2020

Forecast & Opportunities, 2020

Global Tissue Engineered Medical Devices Market

P h a r m a & H e a l t h c a r e C o n s u l t a n t s


Global tissue engineered medical devices market forecast and opportunities 2020

I n d u s t r y B r i e f

Global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020

Increasing aging population, rising number of diabetic patients and various ongoing innovations to drive the

global tissue engineered medical devices market

According to recently published Pharmaion report, “Global Tissue Engineered Medical Devices Market

Forecast And opportunities, 2020”, global tissue engineered medical devices market is anticipated to cross

US$ 26 billion by 2020. A wide array of factors that are expected to positively influence the global tissue

engineered medical devices market during forecast period include increasing aging population, ongoing

technological advancements and growing consumer awareness. Moreover, as compared to artificial implants,

tissue engineered implants offer better biocompatibility, thereby minimizing the probability of rejection of

implant from the body.

Global tissue engineered medical devices market is also driven by the increasing prevalence diabetes and

associated diseases across the globe. Diabetes carries a high risk of cardiovascular diseases and neuropathy.

Neuropathy is among the root causes of foot amputations and ulcers in the diabetic patient, and treatment

process in this case requires skin substitutes. Rising prevalence of diabetes and resulting increase in foot ulcers

is expected to be one of the major factors responsible for the rapid growth of skin substitutes during the forecast

period.

New product launches by existing market players as well as new entrants is expected to boost the global tissue

engineered medical devices market during forecast period. North America dominated the global tissue

engineered medical devices market in 2014, and is anticipated to continue its dominance through 2020 as the

percentage of geriatric population is very high in this region. Moreover, the economic stability of the region also

helps patients to undergo expensive treatment options.

“Global tissue engineered medical devices market will continue to exhibit growth during the next five years.

Growing adoption of nanotechnology and 3D Bioprinting, rising application of engineered protein, and escalating

applications of stem cells are among the major factors driving global tissue engineered medical devices market.

The demand of skin substitutes is increasing at a significant pace on account of rising neuropathy cases among

diabetics and improving efficacy of skin substitute products.” said Mr. Karan Chechi, Research Director with

Pharmaion, a research based global pharmaceutical and healthcare consulting firm.

2

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

1.

Research Methodology

2.

Analyst View

3.

Tissue Engineering Overview

4.

Global Tissue Engineered Medical Devices Market Outlook

4.1.

Market Size & Forecast

4.1.1.

By Value

4.1.2.

By Volume

4.2.

Market Share & Forecast

4.2.1.

By Application

4.2.2.

By Source

4.2.3.

By Region

4.2.4.

By Company

4.3.

Quality Control Policies

5.

Global Tissue Engineered Medical Devices Segmental Market Outlook

5.1.

Global Orthopedic Tissue Engineered Medical Devices Market Outlook

5.1.1.

Market Size & Forecast

5.1.1.1.

By Value

5.1.1.2.

By Volume

5.1.2.

Market Share & Forecast

5.1.2.1.

By Product Type

5.1.2.2.

By Region

3

5.1.2.3.

By Company

5.2.

Global Cardiac Tissue Engineered Medical Devices Market Outlook

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

5.2.1.

Market Share & Forecast

5.2.1.1.

By Value

5.2.1.2.

By Volume

5.2.2.

Market Share & Forecast

5.2.2.1.

By Product Type

5.2.2.2.

By Region

5.2.2.3.

By Company

5.3.

Global Dental Tissue Engineered Medical Devices Market Outlook

5.3.1.

Market Size & Forecast

5.3.1.1.

By Value

5.3.1.2.

By Volume

5.3.2.

Market Share & Forecast

5.3.2.1.

By Product Type

5.3.2.2.

By Region

5.3.2.3.

By Company

5.4.

Global Skin Substitutes Engineered Medical Devices Market Outlook

5.4.1.

Market Size & Forecast

5.4.1.1.

By Value

5.4.1.2.

By Volume

5.4.2.

Market Share & Forecast

5.4.2.1.

By Application

4

5.4.2.2.

By Region

5.4.2.3.

By Company

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

6.

Global Tissue Engineered Medical Devices Regional Market Outlook

6.1.

North America Tissue Engineered Medical Devices Market Outlook

6.1.1.

Market Size & Forecast

6.1.1.1.

By Value

6.1.2.

Market Share & Forecast

6.1.2.1.

By Country

6.1.2.2.

By Application

6.2.

Europe Tissue Engineered Medical Devices Market Outlook

6.2.1.

Market Size & Forecast

6.2.1.1.

By Value

6.2.2.

Market Share & Forecast

6.2.2.1.

By Country

6.2.2.2.

By Application

6.3.

South America Tissue Engineered Medical Devices Market Outlook

6.3.1.

Market Size & Forecast

6.3.1.1.

By Value

6.3.2.

Market Share & Forecast

6.3.2.1.

By Country

5

6.3.2.2.

By Application

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

6.4.

Asia-Pacific Tissue Engineered Medical Devices Market Outlook

6.4.1.

Market Size & Forecast

6.4.1.1.

By Value

6.4.2.

Market Share & Forecast

6.4.2.1.

By Country

6.4.2.2.

By Application

6.5.

Middle East & Africa Tissue Engineered Medical Devices Market Outlook

6.5.1.

Market Size & Forecast

6.5.1.1.

By Value

6.5.2.

Market Share & Forecast

6.5.2.1.

By Country

6.5.2.2.

By Application

7.

Market Dynamics

7.1.

Drivers

7.2.

Challenges

8.

Market Trends & Developments

8.1.

Nanotechnology in Tissue Engineering

8.2.

3D Bioprinting Advancing the Tissue Engineering

8.3.

Bone Tissue Engineering Witnessing Continuous Innovation

8.4.

Increasing Use of Tissue Engineered for Chronic Wound Healing

6

Rising Application of Engineered Protein in Tissue Engineering

8.5.

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

8.6.

Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry

8.7.

Tissue Engineering: Future of Ophthalmology

8.8.

Escalating Use of Stem Cells in Tissue Engineering Research

9.

Competitive Landscape

9.1.

Competition Benchmarking

9.2.

Company Profiles

9.2.1.

Medtronic plc

9.2.2.

Stryker Corporation

9.2.3.

Zimmer Biomet

9.2.4.

DePuy Synthes

9.2.5.

Edwards Lifesciences Corporation

9.2.6.

Smith & Nephew

9.2.7.

Geistlich Pharma AG

9.2.8.

Organogenesis Inc.

9.2.9.

Institut Straumann AG

9.2.10.

CryoLife, Inc.

9.2.11.

Dentsply International

9.2.12.

Integra LifeSciences Corporation

9.2.13.

MiMedx Group, Inc.

9.2.14.

St. Jude Medical, Inc.

9.2.15.

B. Braun Melsungen AG

7

9.2.16.

Wright Medical Technology, Inc.

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Ta b l e o f C o n te n t s

S. No.

Contents

9.2.17.

ACE Surgical Supply Company, Inc.

9.2.18.

BioHorizons IPH, Inc.

9.2.19.

Botiss Biomaterials GmbH

9.2.20.

Cytograft Tissue Engineering

9.2.21.

Mölnlycke Health Care

9.2.22.

TEI Biosciences

10.

Strategic Recommendations

11.

About Us & Disclaimer

8

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

Re s e a rc h M e t h o d o l o g y

Baseline Methodology :

For the study, Pharmaion has gathered information through primary research with respondents in tissue engineered

medical devices market across the globe, followed by external validation of the information by interviewing the

users. We also gathered insights through an exhaustive search of credible paid databases and our internal

database. Our team of analysts has prudently evaluated all the collected information and presented the same in

chronological order to depict a meaningful and clear picture of tissue engineered medical devices in all the regions

across the world.

While compiling the data, we have also validated all the collected information from multiple sources and data

warehouses, in order to present the most accurate and precise information of the concerned industry. The

information has then been verified through primary research surveys with competitors to arrive at logical figures.

Companies Interviewed

SRI Research, Medtronic Inc., DePuy Synthes, Cryolife, Inc., Wright Medical Technology, Smith & Nephew, Ferentis

Sources :

Company Websites, Company Annual Reports, Government Database (American Academy of Orthopedic Surgeons,

Centers for Disease Control and Prevention, CORDIS, etc.), WHO Reports

9

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

S a m p l e D a t a - S n a p s h o t

Global Tissue Engineered Medical Devices Market

United States Prevalence of

United States Percentage Breakdown

Share, By Source, By Value, 2010-2020F

Cardiovascular Disease in Adults above

of

Deaths

due

to

Cardiovascular

60.00% 60.10% 60.20% 60.30% 60.40% 60.50% 60.60% 60.70% 60.80% 60.90% 61.00%

20 years of Age, By Age, By Sex, 2015

Disease, 2011

(% of total population)

Coronary

Heart

Disease,

10.00%

Others,

10.00%

9

7

35.00% 35.10% 35.20% 35.30% 35.40% 35.50% 35.60% 35.70% 35.80% 35.90% 36.00%

Diseases of

Arteries,

10.00%

5

4

3

3

Stroke,

10.00%

2

1

Heart Failure,

10.00%

2010

2011

2012

2013

2014 2015E 2016F 2017F 2018F 2019F 2020F

High Blood

Pressure,

10.00%

Synthetic Biomaterials

Natural Biomaterials

20-39

40-59

60-79

80+

Global Tissue Engineered Medical Devices Market Share, By

Men

Women

North America Tissue Engineered Medical

Company, By Value, 2014 & 2020F

Devices Market Size, By Value (USD

United States Demand for

Medtronic

plc,

15.00%

Billion), 2010-2020F

12

Others,

25.00%

Kidney Donor, 1990 & 2012

11

Medtronic

plc, 10.00%

10

Others,

10.00%

9

8

7

Kidney

Transp

lant

Opera

tions

Stryker

Corporati

on,

15.00%

5

4

3

2

10000

1

Edwards

Lifesciences

Corporation,

10.00%

Stryker

Corporation,

10.00%

Edwards

Lifescienc

es

Corporati

on,

15.00%

2020F

2014

1000

16,485

Zimmer

Biomet,

15.00%

12,000

1990

Depuy

Synthes,

15.00%

Zimmer

Biomet,

10.00%

2012

Depuy

Synthes,

10.00%

Global Tissue Engineered Medical Devices Market Share, By Application, By Value,

2010-2020F

Global Tissue Engineered Medical Devices

55.90%

56.00%

55.80%

55.70%

55.60%

55.50%

55.40%

55.30%

55.20%

55.10%

55.00%

Market Size, By Value (USD Billion), By Volume

(Million Units), 2010-2020F

25

23

21

19

17

15.00%

14.90%

14.80%

14.70%

14.60%

14.50%

14.40%

14.30%

14.20%

14.10%

15

12

14.00%

11

7.00%

6.90%

6.80%

6.70%

6.60%

6.50%

6.40%

11

6.30%

6.20%

10

6.10%

6.00%

9

9

8

7

7

5

5

4

3

3

4.00%

3.90%

3.80%

3.70%

3.60%

3.50%

3.40%

3.30%

3.20%

3.10%

3.00%

2

1

10

18.00%

17.90%

17.80%

17.70%

17.60%

17.50%

17.40%

17.30%

17.20%

17.10%

17.00%

2010 2011 2012 2013 2014

2015E2016F2017F2018F2019F2020F

2010

2011

2012

Others

2013

2014

Skin Substitute

2015E

2016F

2017F

2018F

2019F

2020F

© Pharmaion

Dental

Value (USD Billion)

Volume (Million Units)


Global tissue engineered medical devices market forecast and opportunities 2020

Re p o r t O rd e r i n g

Report Name: Global Tissue Engineered Medical Devices Market

Forecast and Opportunities, 2020

Report Price

License Type

Price

Single User License

$4000

Single User License Print

$4500

Enterprise License

$8000

To View Sample OR Purchase Report

11

© Pharmaion


Global tissue engineered medical devices market forecast and opportunities 2020

A b o u t U s & D i s c l a i m e r

About Us

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers

with high value market research and advisory services that helps them identify new market opportunities, growth engines and

innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by

legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as

engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports

do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with

comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained

industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting

requirements.

Related Reports

India Stem Cells Market Forecast & Opportunities, 2020

India Infertility Treatment Market Forecast & Opportunities, 2020

Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020

Disclaimer

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made

that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from

various sources including which it considers reliable and first hand.

However, Pharmaion Consultants does not guarantee the accuracy, adequacy or

completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and

especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates

and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s

internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

[email protected]

+1 646 360 1656

www.pharmaion.com

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

[email protected]

+91 - 120 - 452 3900

www.pharmaion.com

12

© Pharmaion


  • Login